Professor Sir David Lane is one of the scientists credited with the landmark discovery of cancer gene p53 in 1979. p53, called the "Guardian of the genome" is considered the most significant of all the genes altered in cancer cells because mutations of the gene are known to cause almost...

Current AppointmentsChairman, Council for Advanced Regenerative Medicine (CARM)Board Member, Korea Institute of S&T Evaluation and PlanningAuditor and Fellow, National Academy of Engineering of KoreaAdvisor, Bio Economy Committee, Government of MalaysiaAdvisor, Rice University Bioengineering...

Dr Carl Firth is the Founder and CEO of ASLAN pharmaceuticals, a Singapore company with offices in Taiwan and China, which is developing novel medicines for global markets in oncology and inflammation. Previously, Carl was the Head of Asia Healthcare at Bank of America Merril Lynch, supporting...

James Cai joined Amgen as Vice President of Regulatory Affairs, Japan Asia Pacific (JAPAC) since May 2014. His focus is to lead and oversee development and implementation of regulatory strategies across multiple countries, which currently includes...

Dr Benjamin Seet was appointed Executive Director of the Biomedical Research Council (BMRC) in 2012. He joined A*STAR) in 2011 and currently oversees its biomedical research institutes, centres and consortia that engage in scientific and translational R&D spanning the pharmaceutical, medical...

Seong-Choon Choe is a highly accomplished medical/clinical/developmental expert with over 16 year-experience. He has extensive experience managing medical, R&D, commercial organization and business development in Korean subsidiary of multinational big pharmaceutical companies as well as Korean...

Dr. Tang has worked as a medical reviewer since 2010, firstly in the Taiwan Food and Drug Administration (TFDA) then in the Center for Drug Evaluation (CDE). TFDA is the competent authority in charge of food, drugs, controlled drugs, medical equipment and cosmetics related management in Taiwan; CDE ...

E. Stewart Geary, M.D, has worked at Eisai since 1996 in pharmacovigilance, clinical safety and regulatory science. He is currently a member of the Executive Committee of the Japanese Association of Pharmaceutical Medicine and serves on the Editorial Advisory Boards for the publications Applied...

A Board certified Oncologist and Haematologist with over 30 years in basic science, academia and industry, as Principal Investigator, Institutional Research Head and Chief Medical Officer, overseeing basic and clinical research. He has been included in the conduct of over a 100 studies with a focus ...

Hardy Chan is the Chairman & President of Allianz Pharmascience,  Helios Bioelectronics and Chairman & Co-founder of Nano Targeting & Therapy Biopharma. Prior to these roles, he served as the former President of Tanvex Biologics and co-founded ScinoPharm Taiwan, both are well known...

Dr Ede has a record of successfully evolving research concepts to commercial products and processes. He has over 25 years experience in drug discovery and international business development gained at Chiron Corporation - now Novartis (VP Chemistry), EqiTX Ltd (COO), Mimotopes Pty Ltd (CEO), Adistem ...

Dr James Garner is CEO of Kazia Therapeutics Limited, an ASX- and NASDAQ-listed, oncology-focused biotech company, based in Sydney Australia. Kazia’s lead program, GDC-0084, was licensed from Genentech in October 2016, and is due to enter a phase II clinical trial in glioblastoma multiforme. A...

Kamal is a trained Chemist who decided to pursue a career in supply chain management and quality. In this role, he was tasked to supervise commercial and clinical trial products. Kamal has worked in the pharmaceutical and device industries for over 10 years in different size organisations ranging...

Dr Anand Gautam has 25 years of leadership in R&D and innovation strategies in Inflammation/Autoimmune Diseases/Cancer at international biotech and pharmaceutical companies. In addition, Anand has spent over 12 years as an academic in Immunology in prestigious research centers in the UK (PhD at ...

Mr. Vishal Doshi, B. Pharm, M.Sc.CEO and Founder of AUM Biosciences. A Pharmacist by training, he is an experienced senior management with extensive experience in clinical research related experience across the Pharmaceutical/CRO Industry. Mr. Doshi is a Key Opinion Leader with the Korean Health...

Shwen is a recognized pioneer in digital health and social pharma, as well as a well-respected industry thought-leader who was named a Top 40 “Healthcare Transformer” by Medical, Marketing and Media in 2015. He brings over a decade of experience leading commercial/brand digital strategy and...

•    Dr. Hema BAJAJ is an Indian by origin, born and brought in the financial capital of India, Mumbai.  •    She is currently the Country Quality Head for Sanofi India, Srilanka, Nepal and Bangladesh, and leads the Medical Governance across the affiliate. She has an experience of over 10 years...

Dr. Seokjoong Kim is an experienced molecular biologist in the field of programmable nuclease development and genome editing technology. Following his Ph.D. studies in the laboratory of Prof. Thomas Boyer at University of Texas Health Science Center at San Antonio, Dr. Kim joined the group of...

Dr. Zhou, Xinhua (Dr. Joe Zhou) is the CEO of Genor Biopharma, a VP and the R&D head of Walvax Bio Group. He has been selected as a national expert of the TOP 1000 TALENTS program in China since 2010. Dr. Zhou also is a visiting professor teaching Master Degree Program in International...

Vicky Han, Senior Director, Group Lead for Regulatory Policy in Asia Pacific at Johnson & Johnson Pharmaceuticals, is currently in charge of Asia Pacific regulatory policy, in particular focusing on China and Japan, while engaging with external stakeholders for improving the regulatory...

Dr Jeonghoon Han is Vice President, CDO and CFO of Medicine Development Division & Management Planning Division at Eutilex, an innovative immuno-oncology biotech company based in South Korea. He is responsible for Eutilex pipeline development, global regulatory approval and global marketing and ...

Dr Hillyard is an experienced senior executive with a background in the life sciences industry. She is currently Deputy Chairman of the Mater Medical Research Institute. Prior roles include State and Federal government boards and committees, advising on biotechnology and venture capital. Dr...

Hironoshin Nomura is a member of Mizuho’s industry-leading Japan Health Care team, and is Mizuho’s lead analyst for Japanese biotech. In that role, he has met with all 43 of Japan’s publicly listed biotech companies, and publishes official research reports (including investment ratings and price...

Piers Ingram, PhD is the Co-Founder and CEO of Hummingbird Bioscience.  After undergraduate studies in applied mathematics, Piers completed his PhD in Systems Biology at Imperial College London funded by the Wellcome Trust Prize Studentship. Piers subsequently held several increasingly senior roles ...

Mario Bertazzoli is a physician and a registered specialist in Human Reproduction Pathology. He received both medical and specialization degrees from the University of Milan, Italy and worked as physician at the Obstetric and Gynaecological Department, University of Milan, and for the Italian...

Dr. William Wei-Guo Jia had his PhD in 1991 at University of British Columbia (UBC) in molecular neurosciences. Since 1999, he has been an associate professor since 1999 at UBC and an associate scientist of BC Cancer Research Centre. Dr. Jia was the first in Canada and the first few scientists in...

Dr Kopsidas has over 18 years experience in protein and antibody drug engineering, 5 years in the fields of molecular ageing and mitochondrial diseases where he held a position on the editorial board for the Bio-Gerontology Journal, and over 10 years elucidating the mechanisms of DNA repair. He had ...

Liping Liu is the founder, CEO & CSO of HighTide Therapeutics, a globally focused company to develop therapeutics for chronic non-viral liver diseases, gastrointestinal diseases and metabolic disorders with large and unsatisfied markets needs. The company’s lead drug is a first-in-class new...

Antonio Bertoletti, MD is an expert in the field of viral hepatitis. He began working in viral hepatitis as a medical student at the University of Parma (Italy). During his MD specialization (1991) in Infectious Diseases he spent two years at The Scripps Research Institute (La Jolla) characterizing ...

When Sook Yee's youngest son Branden was diagnosed with (Spinal Muscular Atrophy) SMA when he was just 1 years old, the awareness of this rare disease in Malaysia was low, with gaps in the standards of care, and it was hard to get support. Those first few years were challenging. When life got...

With more than 18 years of experience in clinical research & operations, Maggie has spent most of her time in R&D early phase clinical development, led regional training for 5 years  before moving onto Clinical Development Quality Assurance within GSK R&D for the last  4 years. She has...

Chongdeok Park joined KOLON Pharma, one of leading Korea based Pharmaceutical companies and is responsible for development in R&D, including portfolio management, external R&D Collaboration, medical affairs, regulatory affairs, market access and business development.  Prior to Kolon...

In 2011, Edmund’s younger son Branden was diagnosed with Spinal Muscular Atrophy (SMA). It was difficult to find care and support for SMA in Malaysia and the standards of care were relatively poor.  A few years later, he founded We CARE Journey (www.wecarejourney.org), a not-for-profit with a...

Financially independent since age 13 (1997), Wharton graduate (2009), lived and worked in the US, China and Singapore, plus extensive operating and investment experience in Europe. Transformed Esco into a global life science and medical equipment manufacturer and solutions provider, growing...

Hui Hsing Ma has worked with TVM Capital Group since 2004 in various roles of Advisor, Venture Partner and General Partner for East Asia with TVM Life Sciences venture capital team. She is currently a Senior Advisor for Southeast Asia with the TVM Healthcare private equity firm. She brings over 15...

Alex Matter is CEO of the Experimental Therapeutics Centre since April 2009 and since January 2012 CEO of the newly created D3 platform, A*STAR, Singapore. Previously, he had spent five and a half years as Director of the Novartis Institute for Tropical Diseases (NITD), from October 2003 to...

Life sciences and digital health investor with systems-based perspective presently preparing for launch of inaugural fund. Prior to this led life sciences and digital health practice for Oliver Wyman in Asia, co-founded medical device company in real-time brain imaging, and worked at a...

Charles has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He now leverages this breadth of experience in leading Accera in the fight against Alzheimer's and other neurological diseases.Prior to joining Accera, Charles was with Inventages, a global...

Sabrina Ng is the Chief Financial Officer of Hummingbird Bioscience where she is responsible for overseeing most Business Support functions including Finance, Human Resources, Operations and Fund-raising.  She has led Hummingbird’s various fund-raising rounds, including dilutive and non-dilutive...

Charles Dwo Yuan SIA is the Chief Technology Officer of BravoVax. He was an Investigator (Professor) of National Institute of Infectious Diseases and Vaccinology at National Health Research Institutes, Taiwan. Prior of joining NHRI, he was the Director of Immunology and Vaccinology in UBI (USA)...

Dr. Lietao Li is the co-founder, chairman of the board, and CEO of Lion TCR Pte. Ltd.  Dr. Li has over 20 years of biopharmaceutical industrial experience and 4 years of clinical experience. Dr. Li founded his first biotech company specializing in vaccine development, where he served as the...

Sam Shen has 24 years of experience in the biological pharmaceutical industry, including cytokines, Mab, cell therapy products. He is familiar with manufacturing process, QC, QA, QM of biological products in R&D and commercial stage. He is also skillful in quality system construction.

Dr. Poon is currently the President of Quacell Biotech Ltd. He previously worked for Hisun Biopharm, Merck (SAFC), Roskamp Institute in USA. He completed his Ph.D. in Biological Chemistry at University of Kentucky, and MBA from University of South Florida. He has years of experience in the field of ...

Wonsang “Robert” Yu is the Director of Sales of Yuyu Pharma and its subsidiaries. Yuyu Pharma was found by Robert’s grandfather in 1941. The company manufactures, distributes, and sales pharmaceutical products, as well as medical devices, medical foods and cosmetics in South Korea and Southeast...

Dr. Ong is an accomplished scientist, with experience in multiple advanced fields, including cell and molecular biology, genetics, genomics, diagnostics and drug development. Since 1995, she has been conducting pioneering research in academic and industry settings at the Institute of Molecular and...

Gopal Rao is part of the Global BD and Licensing team at Lupin Biotech based out of the Biotech Division of Lupin at Pune, India, responsible for product evaluation, commercial launch strategy, Evaluating and finalizing B2B licensing partners in Japan and Emerging markets along with liaising with...

Yongho Oh, MPH, PMP, is the Regional Clinical Project Manager & ISS Project Manager for Asia, JPAC and China region in Sanofi. With over a decade of experience, Yongho oversees the project management activities related to various clinical trials, epidemiology and pharmaco-epidemiology...

Crystal Sun, Master Degree of Tumor Pharmacology, graduated from Tsinghua University. She has more than 8 years drug registration, regulatory affair and project management experience, in charge of registration of chemical drugs, traditional Chinese medicines and biologics. Crystal Sun joined Fosun...

Gavin Teo is a General Partner at B Capital Group, a US and Singapore-based VC firm, where he leads the firm’s healthcare investments and heads the San Francisco office. Mr. Teo serves as a Board Director for AIMotive, Atomwise, Bright.md, Fishbrain and SilverCloud Health and co-manages the firm’s...

Dr.G.S.Reddy is the Senior Vice President of Brilliant BioPharma and former Chief General Manager of Indian Immunologicals Limited, a major veterinary and human vaccines manufacturer in India. He obtained basic degree in Veterinary medicine in 1981 from Andhra Pradesh Agricultural...

Hsiao-Hui Tsou (Sophie) received her Ph.D. in Mathematical Statistics from the University of Maryland, College Park, in 2005. She did her post-doctoral training in Division of Biostatistics and Bioinformatics, National Health Research Institutes, Taiwan (2005-2008). She was reappointment to be an...

During the previous stints with pharmaceutical and ITES/CRO organizations, Mrunalini has exhibited expertise in steering global clinical data management projects conducted across US, EU & APAC to successful completion. Currently, she is associated with SICS A*STAR where she is leading data...

Dr Yeo Jing Ping is the Director for Research Integrity, Compliance and Ethics in Singapore Health Services Pte Ltd.  In her role in the institution, she leads a team that is responsible for ensuring proper oversight of research quality, integrity and compliance.She has more than 20 years of...

Arani Chatterjee, MBBS, MPhil, PGCPM completed his graduation from CMC, Vellore and post-graduation from NIMHANS, Bangalore. He has a Post Graduate Certificate in Management from IIM, Indore. Before joining Aurobindo Pharma, he was Senior Vice President, Clinical Research at Biological E, Hyderabad ...